Cadence Bank Eli Lilly & CO Transaction History

Cadence Bank

$1.45 Billion
Q3 2024

A detailed history of Cadence Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Cadence Bank holds 11,811 shares of LLY stock, worth $8.83 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

11,811

Previous 12,928 8.64%

Holding current value

$8.83 Million

Previous $11.7 Million 10.6%

% of portfolio

0.72%

Previous 0.88%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $862,480 - $1.07 Million	-1,117 Reduced 8.64%	11,811 $10.5 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $63,788 - $79,995	-88 Reduced 0.68%	12,928 $11.7 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $319,788 - $427,831	540 Added 4.33%	13,016 $10.1 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $91,908 - $108,347	-175 Reduced 1.38%	12,476 $7.27 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $55,641 - $76,710	-128 Reduced 1.0%	12,651 $6.8 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $93,998 - $125,686	-268 Reduced 2.05%	12,779 $5.99 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $272,733 - $320,311	878 Added 7.22%	13,047 $4.48 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $57,879 - $67,440	180 Added 1.5%	12,169 $4.45 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $3.09 Million - $3.52 Million	10,416 Added 662.17%	11,989 $3.88 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $8,361 - $9,818	30 Added 1.94%	1,573 $510,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $3,050 - $3,791	13 Added 0.85%	1,543 $442,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $31,596 - $40,869	175 Added 12.92%	1,530 $351,000
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $657 - $850	-4 Reduced 0.29%	1,355 $253,000
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $2,339 - $2,706	-16 Reduced 1.16%	1,359 $201,000
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $187,577 - $225,747	1,375 New	1,375 $226,000
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $199,408 - $246,811	-1,675 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $179,091 - $221,820	1,675 New	1,675 $220,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $213,049 - $248,682	-1,923 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $30,053 - $35,375	-270 Reduced 12.31%	1,923 $250,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $29,652 - $33,219	280 Added 14.64%	2,193 $254,000
Q3 2018 Oct 25, 2018	BUY	$85.86 - $107.31 $164,250 - $205,284	1,913 New	1,913 $206,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account